Dieleman JP - Search Results

1

Polypharmacy and falls in the middle age and elderly population.

Ziere G, Dieleman JP, Hofman A, Pols HA, van der Cammen TJ, Stricker BH. Ziere G, et al. Among authors: dieleman jp. Br J Clin Pharmacol. 2006 Feb;61(2):218-23. doi: 10.1111/j.1365-2125.2005.02543.x. Br J Clin Pharmacol. 2006. PMID: 16433876 Free PMC article.

2

[Lipodystrophy and 'buffalo hump' during treatment with HIV protease inhibitors].

Dieleman JP, Hillebrand-Haverkort ME, van der Ende ME, Sturkenboom MC, Lange JM, Stricker BH. Dieleman JP, et al. Ned Tijdschr Geneeskd. 1998 Dec 26;142(52):2856-60. Ned Tijdschr Geneeskd. 1998. PMID: 10065260 Dutch.

3

Papillary necrosis associated with the HIV protease inhibitor indinavir.

Dieleman JP, van der Feltz M, Bangma CH, Stricker BH, van der Ende ME. Dieleman JP, et al. Infection. 2001 Aug;29(4):232-3. doi: 10.1007/s15010-001-1105-y. Infection. 2001. PMID: 11545487

4

Indinavir crystallization around the loop of Henle: experimental evidence.

Dieleman JP, Salahuddin S, Hsu YS, Burger DM, Gyssens IC, Sturkenboom MC, Stricker BH, Kok DJ. Dieleman JP, et al. J Acquir Immune Defic Syndr. 2001 Sep 1;28(1):9-13. doi: 10.1097/00042560-200109010-00002. J Acquir Immune Defic Syndr. 2001. PMID: 11579271

5

Determinants of recurrent toxicity-driven switches of highly active antiretroviral therapy. The ATHENA cohort.

Dieleman JP, Jambroes M, Gyssens IC, Sturkenboom MC, Stricker BH, Mulder WM, de Wolf F, Weverling GJ, Lange JM, Reiss P, Brinkman K; ATHENA Study Group. Dieleman JP, et al. AIDS. 2002 Mar 29;16(5):737-45. doi: 10.1097/00002030-200203290-00009. AIDS. 2002. PMID: 11964530

6

Risk factors for urological symptoms in a cohort of users of the HIV protease inhibitor indinavir sulfate: the ATHENA cohort.

Dieleman JP, Sturkenboom MC, Jambroes M, Gyssens IC, Weverling GJ, ten Veen JH, Schrey G, Reiss P, Stricker BH; Athena Study Group. Dieleman JP, et al. Arch Intern Med. 2002 Jul 8;162(13):1493-501. doi: 10.1001/archinte.162.13.1493. Arch Intern Med. 2002. PMID: 12090886 Clinical Trial.

7

Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: the Triumph project.

Verhamme KM, Dieleman JP, Bleumink GS, Bosch JL, Stricker BH, Sturkenboom MC. Verhamme KM, et al. Among authors: dieleman jp. Eur Urol. 2003 Nov;44(5):539-45. doi: 10.1016/s0302-2838(03)00376-2. Eur Urol. 2003. PMID: 14572751

8

The incidence of sudden cardiac death in the general population.

Straus SM, Bleumink GS, Dieleman JP, van der Lei J, Stricker BH, Sturkenboom MC. Straus SM, et al. Among authors: dieleman jp. J Clin Epidemiol. 2004 Jan;57(1):98-102. doi: 10.1016/S0895-4356(03)00210-5. J Clin Epidemiol. 2004. PMID: 15019016

9

Annual revaccination against influenza and mortality risk in community-dwelling elderly persons.

Voordouw AC, Sturkenboom MC, Dieleman JP, Stijnen T, Smith DJ, van der Lei J, Stricker BH. Voordouw AC, et al. Among authors: dieleman jp. JAMA. 2004 Nov 3;292(17):2089-95. doi: 10.1001/jama.292.17.2089. JAMA. 2004. PMID: 15523069

10

Low incidence of acute urinary retention in the general male population: the triumph project.

Verhamme KM, Dieleman JP, van Wijk MA, Bosch JL, Stricker BH, Sturkenboom MC. Verhamme KM, et al. Among authors: dieleman jp. Eur Urol. 2005 Apr;47(4):494-8. doi: 10.1016/j.eururo.2004.11.011. Epub 2005 Jan 15. Eur Urol. 2005. PMID: 15774248

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters